glutamic acid has been researched along with Cancer Pain in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fazzari, J; Linher-Melville, K; Singh, G | 1 |
BassiriRad, NM; Bui, L; Doyle, T; Forte, BL; Largent-Milnes, TM; Mantyh, PW; Neumann, WL; Salvemini, D; Slosky, LM; Staatz, WD; Symons, AM; Thompson, M; Vanderah, TW | 1 |
Gao, Y; Huang, X; Ke, C; Li, Y; Liu, J; Luo, J; Shi, R; Xu, X; Yao, W | 1 |
3 other study(ies) available for glutamic acid and Cancer Pain
Article | Year |
---|---|
Tumour-Derived Glutamate: Linking Aberrant Cancer Cell Metabolism to Peripheral Sensory Pain Pathways.
Topics: Afferent Pathways; Animals; Cancer Pain; Glutamic Acid; Humans; TRPV Cation Channels | 2017 |
The cystine/glutamate antiporter system xc- drives breast tumor cell glutamate release and cancer-induced bone pain.
Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiporters; Bone Neoplasms; Breast Neoplasms; Calcium-Binding Proteins; Cancer Pain; Cell Line, Tumor; Disease Models, Animal; Female; Gene Expression Regulation, Neoplastic; Glutamic Acid; Heterografts; Metalloporphyrins; Mice; Mice, Inbred BALB C; Peroxynitrous Acid; Sulfasalazine; Time Factors | 2016 |
GPR30 disrupts the balance of GABAergic and glutamatergic transmission in the spinal cord driving to the development of bone cancer pain.
Topics: Animals; Bone Neoplasms; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cancer Pain; Disease Models, Animal; Female; GABAergic Neurons; Gene Expression Regulation; Glutamic Acid; Posterior Horn Cells; Rats; Receptors, G-Protein-Coupled; Receptors, GABA; Spinal Cord; Synaptic Transmission | 2016 |